摘要
Alzheimer's disease (AD) is the most common type of dementia and is a serious social and medical problem threatening human health. The present study investigated the effect and underlying action mechanism of triptolide (Tri) on AD progression. Reverse transcription-quantitative PCR and western blotting analysis were used to determine the changes in RNA expression and levels of NF-kappa B signaling pathway proteins before and after lipopolysaccharide (LPS) induction. Nucleocytoplasmic separation experiments determined the intracellular localization of long non-coding RNA (lncRNA) nuclear paraspeckle assembly transcript 1 (NEAT1). A dual-luciferase assay was used to analyze the binding between NEAT1 and microRNA (miRNA/miR)-361 or tumor necrosis factor receptor-associated factor 2 (TRAF2) and miR-361-3p and RNA pull-down was used to analyze the binding between NEAT1 and miR-361-3p. Cell Counting Kit-8, flow cytometry and ELISA were used to detect the effects of interaction between Tri and NEAT1/miR-361-3p/ TRAF2 on cell viability, apoptosis and inflammatory factor levels, respectively. The results showed that LPS-mediated human microglial clone 3 cell line (HMC3) viability decreased and apoptosis and inflammatory factors (IL-1 beta, IL-6, IL-18 and TNF-alpha) increased. Tri inhibited LPS-mediated effects in a dose-dependent manner by downregulating NEAT1 expression. NEAT1 is highly expressed in the cytoplasm and reduces the transcription and translation of downstream TRAF2 by acting as a competitive endogenous RNA that adsorbs miR-361-3p. LPS-mediated HMC3 cell injury, inflammation and activation of NF-kappa B signaling were partially reversed in presence of Tri. The miR-361-3p mimic promoted the Tri effect and overexpression of (ov)-NEAT1 partially reversed the Tri-miR-361-3p combined effect. The effects of ov-NEAT1 were partially attenuated by small interfering (si)-TRAF2. Overall, Tri inhibited the LPS-induced decrease in viability, increase in apoptosis and inflammation and activation of NF-kappa B signaling in HMC3 cells. Tri regulation affected the NEAT1/miR-361-3p/TRAF2 axis. These findings suggested a potential therapeutic role for Tri in the clinical management of AD by modulating this molecular axis.
学科与关键词
- LncRNA RMRP accelerates autophagy-mediated neurons apoptosis through miR-3142/TRIB3 signaling axis in alzheimer's diseaseTang, Zhan-Bin; Chen, Hong-Ping; Zhong, Di; Song, Ji-He; Cao, Jing-Wei; Zhao, Mian-Qiao; Han, Bai-Chao; Duan, Qiong; Sheng, Xiao-Meng; Yao, Jia-Lin; Li, Guo-Zhong*Brain Research, 2022, 1785: 147884.被引 11
- Trilobatin Alleviates Cognitive Deficits and Pathologies in an Alzheimer's Disease Mouse ModelDing, Jiuyang; Huang, Jian; Yin, Dan; Liu, Ting; Ren, Zheng; Hu, Shanshan; Ye, Yuanliang; Le, Cuiyun; Zhao, Na; Zhou, Hongmei; Li, Zhu; Qi, Xiaolan; Huang, JiangOxidative Medicine and Cellular Longevity, 2021, 2021: 3298400.被引 8
- Artemisinin Attenuates Amyloid-Induced Brain Inflammation and Memory Impairments by Modulating TLR4/NF-κB SignalingZhao, Xia; Huang, Xiaosu; Yang, Chao; Jiang, Yizhou; Zhou, Wenshu; Zheng, Wenhua*INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23(11): 6354.被引 13
